Wednesday, 10 February 2016
Last updated 8 hours ago
Mar 18 2014 | 12:47pm ET
Hedge funds warmed up in February, even if the weather did not.
The Barclay Hedge Fund Index rose 2% last month, erasing its January loss and leaving it up 1.59% on the year. The rally was led by healthcare and biotechnology funds, which rose 5.01% in February and are up 11.19% on the year.
“Improving investor sentiment fuelled by robust M&A activity and strong corporate earnings helped most global equity markets rebound in February, with the exception of China, Japan and Russia,” BarclayHedge founder Sol Waksman said.
Technology funds added 3.24% in February, distressed securities funds 3.04%, event-driven funds 2.91%, equity long-bias funds 2.91% and European equities funds 2.59%. Funds of hedge funds rose 1.66% on the month and are up 1.4% on the year.
With stocks rising—the Standard & Poor’s 500 Index jumped more than 4% in February—short-bias funds took a commensurate hit, dropping 3.87%. Global macro funds shed 0.3% on the month.